Candice Bailey-Smith

Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis

M. Iwamoto, M. Martinho, P. Shaw, 2018, British journal of clinical pharmacology.